John Salerno, Chairman AMENDMENT #1 LETTER OF INTENT TO PURCHASE Personal and Confidential To: Winpoint Health LLC Date

#1 LETTER OF INTENT TO PURCHASE

Amendment to the Letter of Intent

refer to the Letter of Intent ("LOI") between the iGambit Inc. ("IGI") and Winpoint Health Inc. ( Winpoint"

or "Company") and together referred to as ("Parties") dated June 14, 2018 ("Letter of Intent")

with respect to the Acquisition of Winpoint. Capitalized terms used in this amendment letter shall have the same meaning ascribed

Parties agree to herewith amend the Letter of Intent as follows:

of Transaction. IGI would buy certain assets of "Winpoint". The assets to be purchased ("Purchased Assets")

are all the assets, tangible and intangible, of any description held by Winpoint used in conducting its Chronic Care Management

business. The Purchased Assets will be placed in IGI's wholly owned subsidiary HealthDatix Inc.

Prior to closing Winpoint will have secured a minimum $2,000,000 equity investment to be placed into IGI concomitant with

closing of the Transaction, 100% of the proceeds to be used for repayment of certain debt and bridge financing, and for working

capital for the post Transaction consolidated company (IGX and its subsidiary HealthDatix Inc.). In exchange for the equity investment

the equity investors shall receive securities of IGI equal to approximately 35% of the issued and outstanding shares of IGI post

Transaction. At closing of the Transaction, the equity investors are prepared to accept IGI preferred securities.

to the Letter of Intent

Price of Purchased Assets. As consideration for the "Purchased Assets", Winpoint shareholders shall receive equity

in IGI convertible to approximately 30% of the equity of IGI post Transaction, terms and structure to be mutually determined prior

to closing of the Transaction. At closing of the Transaction Winpoint is prepared to accept IGI securities other than IGI Common

party may Terminate this LOI upon thirty (30) days written notice without any liability whatsoever on either party hereto or the

Company and no party hereto or the Company shall be entitled to any form of reimbursement or relief whatsoever, including, without

limitation, injunctive relief, specific performance or damages. Upon the termination of this letter, all of the terms hereof shall

be of no further force or effect with the exception of the terms and provisions set forth in paragraphs 10 and 13 of this letter.

and agreed by the Parties as of September 7, 2018.